STOPDAPT-2 Risk Subgroup Calculator
Patient subgroup context
Record relevant clinical features to review the evidence context. This tool does not calculate an individual event probability.
No subgroup review yet
Select the available clinical features and choose “Review subgroup context.” The tool will summarize relevant evidence without generating an unsupported risk percentage.
STOPDAPT-2 subgroup characteristics are not a validated individual prediction model. The result is an evidence summary, not a treatment recommendation.
Do not use this tool alone to determine DAPT duration. Individual ischemic and bleeding risks, procedural details, patient preferences, and current guidelines require clinician assessment.
About STOPDAPT-2 ACS
STOPDAPT-2 ACS compared clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy (DAPT) with 12-month DAPT in patients with ACS undergoing PCI. The abbreviated strategy did not meet the prespecified criterion for noninferiority for the primary composite endpoint.
Reported 1-year outcomes in STOPDAPT-2 ACS
| Outcome | 1–2-month DAPT | 12-month DAPT | Effect estimate |
|---|---|---|---|
| Primary composite endpoint | 3.2% | 2.8% | HR 1.14 (95% CI 0.80–1.62); noninferiority P=.06 |
| Cardiovascular endpoint | 2.7% | 1.9% | HR 1.50 (95% CI 0.99–2.26) |
| TIMI major/minor bleeding | 0.5% | 1.2% | HR 0.46 (95% CI 0.23–0.94) |
These are trial-arm event rates, not individualized predictions and not outputs calculated from the selected patient characteristics.
How to interpret subgroup features
- ACS: the ACS-specific randomized trial did not establish noninferiority of the abbreviated DAPT strategy for its primary endpoint.
- HBR and complex PCI: these are clinically important dimensions of DAPT decision-making. Published subgroup analyses do not justify multiplying a generic baseline risk by arbitrary factors to produce an individual event probability.
- Age: age is relevant to overall clinical assessment but is not an input to a validated STOPDAPT-2 risk equation in this tool.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.